Concepedia

S. Shak

SS

Statistics

Publications

22

Citations

2.4K

H-Index

14

Active since

1999

Affiliations

Genomic Health (United States)(Current)

Indiana University – Purdue University Indianapolis

University of Pittsburgh

Ludwig-Maximilians-Universität München

Federal Highway and Transport Research Institute

S. Shak is an author at Genomic Health (United States) specializing in oncology, medicine, and molecular oncology.

Publications per year

1999–2021

22

Publications

22

Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Michael S. Gordon, Kim Margolin, Moshe Talpaz et al. · Journal of Clinical Oncology · 2001 · 919 citations

, , +17

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Lawrence J. Solin, Robert P. Gray, Frederick L. Baehner et al. · JNCI Journal of the National Cancer Institute · 2013 · 523 citations · Full text

, , +16

Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group.

S. Shak · PubMed · 1999 · 288 citations

, , +16

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories

Frederick L. Baehner, Ninah Achacoso, Tara Maddala et al. · Journal of Clinical Oncology · 2010 · 134 citations · Full text

, , +14

Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue

Lida A. Mina, Sharon E. Soule, Sunil Badve et al. · Breast Cancer Research and Treatment · 2006 · 111 citations

, , +16

1–5 of 22